Crane Company Q2 sales rise 26%, beat estimates; outlook raised
CR•Full-year outlook raised
The company raised its 2026 adjusted EPS outlook to $6.85-$7.05 from $6.65-$6.85.
Crane said it now expects 2026 total sales growth in the mid-20% range, up from its prior view for low-to-mid-20% growth, and sees 2026 adjusted segment operating margin of 23.0% or higher.
Key reported metric and analyst view
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Sales | Beat | $724.7 mln | $706.22 mln (8 analysts) |
The current average analyst rating on the shares is buy, with 11 strong buy or buy ratings, no hold ratings and no sell or strong sell ratings.
Wall Street's median 12-month price target for Crane Co is $232.50, about 2.7% above its July 27 closing price of $226.44.
